# Study of Sulfasalazine in Treating Painful Neuropathy

> **NCT01667029** · PHASE2 · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 8 (actual)

## Conditions studied

- Painful Neuropathy

## Interventions

- **DRUG:** Sulfasalazine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01667029
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-05
- **Primary completion:** 2017-08-10
- **Final completion:** 2017-08-10
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** poor enrollment
- **Last updated:** 2018-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01667029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01667029, "Study of Sulfasalazine in Treating Painful Neuropathy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01667029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*